ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990